Contact Information: CONTACT: Michael Brennan Chairman Email: Telephone: (805) 557-0614
MIT's Distributor in Malaysia Purchases MIT 1000 System
| Source: Micro Imaging Technology, Inc.
SAN CLEMENTE, CA--(Marketwire - October 21, 2009) - Micro Imaging Technology, Inc. (OTCBB : MMTC ) announced that Biotek Sdn Bhd has purchased its first MIT 1000
System. MIT recently signed Biotek Sdn Bhd as its Distributor for Malaysia
and other Association of Southeast Asian Nations (ASEAN) which includes
Indonesia, Singapore, The Philippines, Thailand, Cambodia and others.
Biotek is a premier distributor in the food protection market and
distributes products that are complementary to the MIT 1000 Rapid Microbial
Identification System. "Our sales strategy is to demonstrate the features
and benefits of this System in typical applications, enabling prospective
clients to immediately understand its value. We have found this approach
produces much faster sales than other traditional methods," stated Biotek's
Director, W.C. Fong. Mr. Fong further stated, "We are pleased to add the
MIT 1000 System to our product portfolio. Its rapid test time coupled with
its low operating cost will be attractive to many of our customers."
Biotek will demonstrate the MIT 1000 System in December at the
International Congress of Malaysian Society for Microbiology and will
conduct various local hands-on workshops with the MIT 1000 System.
"Adding Biotek to our distribution network provides MIT with sales channels
throughout the major countries in Asia. MIT already has distributors in
China, Taiwan, South Korea, Japan, and Vietnam," stated John Ricardi, MIT's
Executive Vice President. Mr. Ricardi further stated, "Our
commercialization plan remains on track and we plan to add other key sales
channels and a global contract manufacturer in the near term."
About Biotek Sdn Bhd:
Biotek is registered with the Registrar of Companies in Malaysia and with
the Malaysian Ministry of Finance. It is fully owned by Focus Biotech Sdn
Bhd which has numerous customers in the research, government and commercial
sectors. The company's main focus is in sales, marketing and distribution
of research and scientific products for the ASEAN countries (namely
Malaysia, Singapore, Thailand, Brunei, Indonesia, Philippines, Vietnam,
Cambodia, Laos and Myanmar). It is determined to be one of the best
biotechnology companies serving the ASEAN countries. Biotek Sdn Bhd has
facilities in Malaysia and Singapore that include demonstration, training
and application laboratories for life sciences, biotechnology and clinical
diagnostic applications.
More information on Biotek Sdn Bhd can be found at www.focusbiotech.com.my
About Micro Imaging Technology:
MIT is a California-based public company that has developed and patented a
rapid microbial identification (ID) System that revolutionizes the
pathogenic bacteria ID process and can annually save thousands of lives and
tens of millions of dollars. The System IDs bacteria in minutes, not days,
and at a significant per test cost savings when compared to any
conventional method. It does not rely on chemical or biological agents,
conventional processing, fluorescent tags, gas chromatography or DNA
analysis. The process is totally GREEN requiring only clean water and a
sample of the unknown bacteria. Revenues for all rapid testing methods
exceed $5 billion annually -- with food safety accounting for over $3
billion -- having expanded at a rate of 9.2 percent annually since 1998.
Current growth projections are at 30 percent annually with test demands
driven by major health, safety and homeland security issues. www.micro-imaging.com
MIT recently completed an extensive, almost one-year in duration,
evaluation by the AOAC Research Institute which included independent
rigorous testing and thorough reviews by the AOAC RI and its expert
reviewers, including the U.S. Department of Agriculture. The AOAC RI Report
is available from the Company. www.aoac.org
Further, MIT has demonstrated the ability to detect and identify, within
several minutes, the microbes Escherichia coli, Listeria, Salmonella,
Staphylococcus aureus, and other pathogenic bacteria. MIT recently
performed over 300 tests for the identification of the aforementioned
contaminants and scored 95% accuracy. The System can currently identify 23
species of bacteria and is easily expandable. The identification process
has been verified by North American Science Associates, Inc. (NAMSA), an
independent, internationally recognized biological testing laboratory. The
NAMSA Test Report is available from the Company and, in MIT's opinion,
demonstrates the accuracy, speed and cost effectiveness of the System over
conventional processes. www.namsa.com
This release contains statements that are forward-looking in nature.
Statements that are predictive in nature, that depend upon or refer to
future events or conditions or that include words such as "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and similar
expressions are forward-looking statements. These statements are made
based upon information available to the Company as of the date of this
release, and we assume no obligation to update any such forward-looking
statements. These statements are not guarantees of future performance and
actual results could differ materially from our current expectations.
Factors that could cause or contribute to such differences include, but are
not limited to dependence on suppliers; short product life cycles and
reductions in unit selling prices; delays in development or shipment of new
products; lack of market acceptance of our new products or services;
inability to continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and other
factors and risks associated with our business are discussed from time to
time within our filings with the Securities and Exchange Commission.